Search

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.

… Wednesday, October 9, 2013 Summary Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries. This image shows a cross section of a piece of tissue that was surgically

This photo essay showcases the critical role trainees play within MSK's research enterprise.

… Tuesday, September 3, 2024 The students and postdoctoral researchers who work and train in MSK’s laboratories drive discovery forward every day. Today they are vital partners. Tomorrow they will lead further progress at hospitals, research centers, and biomedical companies around the world.   Monica

People with bladder cancer may soon have a new treatment option following surgery.

… Thursday, May 13, 2021 Update: On August 19, 2021, the US Food and Drug Administration approved nivolumab for patients with bladder cancer who are at high risk of recurrence following surgery to remove the bladder.  People whose bladder cancer has spread into the muscle wall may soon have a new treatment

Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR.

… Wednesday, June 6, 2012 Summary Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR. Bayard D. Clarkson, of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program

Memorial Sloan Kettering Cancer Center (MSK) today celebrates its 26th year of the "holiday hallway." Each year during December, MSK’s carpenters, toolmakers, locksmiths, electricians, and painters construct a winter wonderland in the basement hallway of MSK for patients, families, and staff to visit and enjoy. The decades-long tradition brings joy and cheer to all and has grown in size and detail year after year. The “holiday hallway” is a labor of love for MSK’s Facilities staff, who give of themselves to create the magical MSK tradition. 

… Thursday, December 12, 2019 Today Show host, Hoda Kotb, takes a selfie with MSK’s Department of Facilities in MSK’s Holiday Hallway Today Show host, Hoda Kotb, takes a selfie with MSK’s Department of Facilities in MSK’s Holiday Hallway Memorial Sloan Kettering Cancer Center (MSK) today celebrates its

Learn about magnesium's essential role in overall health and in cancer treatment and prevention. Dr. Urvi Shah answers questions about diet, supplements, and what the research shows.

… Monday, September 30, 2024 Magnesium is having a big moment, as its boosters take to social media to tout the mineral’s potential to do everything from relieve anxiety and facilitate sleep to lower blood pressure and cure constipation. Naturally abundant in certain foods and widely available in supplement

Researchers from MSK presented promising studies on treating rare solid tumors including mesothelioma and three types of soft-tissue at the annual meeting of the American Society of Clinical Oncology.

… Monday, June 3, 2024 Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented several promising studies on treating rare solid tumors at the annual meeting of the American Society of Clinical Oncology (ASCO). The results of clinical trials focused on mesothelioma and three types of soft-tissue

Learn how a new cancer engineering PhD program is attracting leading scientists to come to MSK.

… Friday, September 13, 2024 A visionary new approach to solving problems in cancer science is now fully underway at Memorial Sloan Kettering Cancer Center (MSK), as the inaugural class begins  the Pat and Ian Cook Doctoral Program in Cancer Engineering . Leading researchers — drawn to MSK by the opportunity

Following an approval from the FDA in May 2020, the New England Journal of Medicine has published data from the phase I/II LIBRETTO-001 clinical trial of selpercatinib in advanced RET (REarranged during Transfection)-driven lung and thyroid cancers. MSK’s Alexander Drilon, MD, the recently appointed Chief of the Early Drug Development Service, serves as the lead investigator for multi-site clinical trial.

… Wednesday, August 26, 2020 Results Mark Significant Advances in Targeted Treatment for RET-Driven Cancers, Advancing the Field of Precision Medicine Following an approval from the U.S. Food and Drug Administration (FDA) in May 2020, the New England Journal of Medicine has published data from the phase

Two intraperitoneal chemotherapy approaches are being compared for effectiveness and toxicity in Memorial Sloan Kettering Cancer Center’s phase II clinical trial, which continues to enroll cytoreductive cancer surgery patients with isolated peritoneal metastasis.

… Thursday, May 19, 2016 After surgical cytoreduction Figure 1. After surgical cytoreduction, percutaneous inflow and outflow catheters and IP temperature probes are placed in the peritoneal cavity. The catheters are connected to the perfusion system, and normal saline is heated to 41-43°C and circulated